variant Creutzfeldt-Jakob Disease (vCJD)

Inquiry status: oral evidence concluded

The Science and Technology Committee held an oral evidence session on variant Creutzfeldt-Jakob Disease (vCJD) and the ongoing risk it poses to the UK. The Committee heard evidence from scientific experts on the potential prevalence of vCJD in the population, modes of ongoing transmission and current UK surveillance, control and prevention strategies.



  • Close


    • Reports and associated evidence – Reports of Committee inquires. This category may also include Special Reports where they are used by a Committee to bring matters relating to conduct of its business to the notice of the House.
    • Responses to Reports - Responses may be published as a Special Report, or as a Command Paper. They may also be appended to a Report should the Committee have substantial comments on the Response, in which case they can be found listed under Reports. 
    • Other oral and written evidence - Evidence taken by the Committee that has yet to or did not result in the publication of a Report. This includes transcripts of recent meetings.
    • Estimate Memoranda - An Estimate memorandum is an explanatory note that accompanies a government department’s estimate (a means by which a department seeks authority from Parliament for its spending plans).
    • Correspondence - Correspondence sent from or received by the Committee or its Chair.
  • 27 Nov 2013 - variant Creutzfeldt-Jakob Disease (vCJD) - oral evidence | PDF version (PDF313 KB) HC 846 | Published 03 Dec 2013

    Evidence given by Professor James Ironside, Professor of Clinical Neuropathology, National CJD Research and Surveillance Unit, University of Edinburgh, Dr Roland Salmon, Joint Chair, Advisory Committee on Dangerous Pathogens TSE Sub Group, and Professor John Collinge, Professor of Neurology, UCL Institute of Neurology and Director of the MRC Prion Unit.